Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
145.50
+1.31 (0.91%)
At close: Apr 28, 2026, 4:00 PM EDT
145.50
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Novartis AG Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Novartis AG stock have an average target of 144, with a low estimate of 118 and a high estimate of 170. The average target predicts a decrease of -1.03% from the current stock price of 145.50.
Analyst Consensus: Hold
* Price targets were last updated on Mar 26, 2026.
Analyst Ratings
The average analyst rating for Novartis AG stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 2 | 2 |
| Hold | 4 | 2 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 5 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $143 → $170 | Buy | Maintains | $143 → $170 | +16.84% | Mar 26, 2026 |
| Barclays | Barclays | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jan 6, 2026 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Dec 8, 2025 |
| Jefferies | Jefferies | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $119 → $118 | Hold → Strong Sell | Downgrades | $119 → $118 | -18.90% | Sep 12, 2025 |
Financial Forecast
Revenue This Year
57.98B
from 56.67B
Increased by 2.30%
Revenue Next Year
61.03B
from 57.98B
Increased by 5.27%
EPS This Year
8.97
from 7.15
Increased by 25.42%
EPS Next Year
9.83
from 8.97
Increased by 9.63%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 62.2B | 67.4B | ||||||
| Avg | 58.0B | 61.0B | ||||||
| Low | 53.8B | 55.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.8% | 16.3% | ||||||
| Avg | 2.3% | 5.3% | ||||||
| Low | -5.1% | -3.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.05 | 11.08 | ||||||
| Avg | 8.97 | 9.83 | ||||||
| Low | 7.39 | 7.88 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 40.5% | 23.5% | ||||||
| Avg | 25.4% | 9.6% | ||||||
| Low | 3.4% | -12.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.